Your session is about to expire
← Back to Search
Part 2: Cohort 1 VRG50635 for Healthy Subjects
Study Summary
"This trial aims to see if VRG50635 is safe for use and how well the body absorbs it."
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Frequently Asked Questions
Do I meet the necessary criteria to participate in this clinical investigation?
"To be eligible for this clinical investigation, participants must be in good health and aged between 19 to 55 years. The trial aims to enroll approximately 30 individuals."
Are there ongoing efforts to actively enroll participants for this medical study?
"As per clinicaltrials.gov, the current trial is not in active recruitment. It was initially listed on 2/28/2024 and last revised on 2/22/2024. While this specific study does not currently seek participants, there are a substantial number of 796 other ongoing trials that are enrolling individuals at this moment."
Is the recruitment for this clinical trial restricted to individuals younger than 55 years old?
"Eligible candidates for this research endeavor are individuals aged between 19 and 55 years. Notably, there are 67 trials tailored for those under 18, along with an additional 375 aimed towards participants over the age of 65."
Is the FDA in agreement with Part 1: VRG50635 Sequence B, A, C?
"Based on the Phase 1 nature of this trial with limited safety and efficacy data, our team at Power rates Part 1: VRG50635 Sequence B, A, C as a level 1 in terms of safety."
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger